However the recombinant IL-10 supplement therapy does not benefit IBD, which indicates that single supplement of IL-10 is not sufficient to control inflammation in IBD patients without controlling the pro-inflammatory cytokines8, 9. Here, IL10 is linked to inflammatory bowel disease.